| For: | Qi GX, Zhao RX, Gao C, Ma ZY, Wang S, Xu J. Recent advances and challenges in colorectal cancer: From molecular research to treatment. World J Gastroenterol 2025; 31(21): 106964 [PMID: 40538516 DOI: 10.3748/wjg.v31.i21.106964] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v31/i21/106964.htm |
| Number | Citing Articles |
| 1 |
Xiaoli Mu, Wenjun Meng, Lingnan Zheng. Microenvironment-Driven Reprogramming in Colorectal Cancer Liver Metastasis: Metabolic, Phenotypic, and Immune Adaptation. International Journal of Molecular Sciences 2026; 27(14) doi: 10.3390/ijms27146206
|
| 2 |
Eyad A Makkawy, Nasser Alsindi, Mohammed Makkawi, Areej A Otaif, Sara N Alqahtani, Ftoon A Alenaze. Updated Evidence on the Protective Role of Statins in Colorectal Cancer: A Systematic Review of Clinical and Mechanistic Insights. Cureus 2025; doi: 10.7759/cureus.93454
|
| 3 |
Sheikh Saba Naz, Josep Sabate Ortega. The Role of Next-Generation Probiotics in Colorectal Cancer Pathways: Mechanisms and Therapeutic Potential. Probiotics and Antimicrobial Proteins 2026; 18(3) doi: 10.1007/s12602-025-10745-6
|
| 4 |
Jinsong Su, Tianqi Wan, Shengnan Tian, Baiyun Dai. Aucubin inhibits epithelial-mesenchymal transition and angiogenesis in colorectal cancer via the HDAC6/PI3K/Akt signaling pathway. Naunyn-Schmiedeberg's Archives of Pharmacology 2026; 399(10) doi: 10.1007/s00210-026-05332-7
|
| 5 |
Zuzanna Rogacz, Wiktoria Weronika Pacuła, Wiktor Janas, Magda Markiewka, Paulina Wala, Marcel Madej, Barbara Strzałka-Mrozik. Targeting β-Adrenergic Signaling in Colorectal Cancer: Molecular Mechanisms and Therapeutic Potential of β-Blockers. Cancers 2026; 18(15) doi: 10.3390/cancers18152507
|
| 6 |
Xiao Liu, Shunyuan Wan, Lei Jian, Yi Chen, Shiyi Liang, Ziwei Wang. Role of Ca2+‐Dependent Epithelial‐Mesenchymal Transition in Malignant Progression of Colorectal Cancer: Special Focus on REG Iα/EDNRB. Cancer Medicine 2026; 15(4) doi: 10.1002/cam4.71754
|
| 7 |
Dinh T. P. Le, Tuan D. Pham. Colorectal cancer worldwide: epidemiological trends, economic burden, and the promise of AI-driven solutions. Exploration of Medicine 2025; 6 doi: 10.37349/emed.2025.1001371
|
| 8 |
Gowtham Menon, Thejaswini Anandan, Sakshi Maruti Kolage, Sarath Chandra Shenoy, Onkar Kacharu Lohakare, Akshata Sanjay Ahire, Deepu Ravindran. Theranostics in the management of colorectal cancer. Discover Nano 2025; 20(1) doi: 10.1186/s11671-025-04390-9
|
| 9 |
Sabrina Brigitta Valerie Setiono, Grace Lendawati Amelia Turalaki, Trina Ekawati Tallei. The Evolving Landscape of the Colorectal Cancer Vaccines: From Biological Mechanisms to Translational Therapeutics. Heca Journal of Applied Sciences 2026; 4(1) doi: 10.60084/hjas.v4i1.372
|
| 10 |
Jaemoo Chun, Sarah Shin, Jeeyoun Jung. Integrative Mechanistic Investigation of the Anticancer Effects of Panax notoginseng in Colorectal Cancer. Molecules 2026; 31(5) doi: 10.3390/molecules31050807
|
| 11 |
Tonghai Zhou, Qianyi Wang, Meili Zhang, Yue Huang. Harnessing human tumor organoids for cancer modeling and precision therapy. Protein & Cell 2026; 17(8) doi: 10.1093/procel/pwag007
|
| 12 |
F. Salvà, G. Catani, N. Saoudi, I. Baraibar, J. Ros, M. Rodriguez, C. Salvà de Torres, A. Alcaraz, A. Garcia, R. Comas, F. Ruiz-Pace, A. Rezqallah, R. Dienstmann, J. Tabernero, E. Elez. Retreatment with oxaliplatin-based regimens in refractory metastatic colorectal cancer: characterization of high-response patients. ESMO Gastrointestinal Oncology 2025; 9 doi: 10.1016/j.esmogo.2025.100230
|
| 13 |
Gregory Kelly, Bianca Nowlan, Simon Manuel Tria, Afshin Nikkhoo, Catherine Bond, Vicki Whitehall. Developing New Immunotherapy Approaches for Colorectal Cancer. Cancers 2025; 17(24) doi: 10.3390/cancers17243929
|
| 14 |
Huda Salameh, Nesha Naseem, Muhammad A. Chattha, Joytish Ramesh, Haneen Ramy, Dasa Cizkova, Peter Kubatka, Dietrich Büsselberg. Oncolytic Virotherapy in Colorectal Cancer: Mechanistic Insights, Enhancer Strategies, and Translational Combinations. Cells 2025; 14(24) doi: 10.3390/cells14242006
|
| 15 |
Mansoor-Ali Vaali-Mohammed, Adhila Nazar, Mohamad Meeramaideen, Saleha Khan. Natural and Synthetic Compounds Against Colorectal Cancer: An Update of Preclinical Studies in Saudi Arabia. Current Oncology 2025; 32(10) doi: 10.3390/curroncol32100546
|
| 16 |
Jun Li, Yang Li, Tian Xie. Bridging Realms: Artificial Intelligence Integrates Omics, Generative Models, and Traditional Medicine for Anticancer Drug Innovation. Journal of Pharmaceutical Analysis 2026; doi: 10.1016/j.jpha.2026.101630
|
| 17 |
Himanshu Agrawal, Himanshu Tanwar, Nikhil Gupta. Tumor organoids in translational cancer research: Models for personalized therapy. World Journal of Translational Medicine 2026; 12(1): 113050 doi: 10.5528/wjtm.v12.i1.113050
|
| 18 |
Lin Liao, Zhaohui Tang, Pengfei Luo, Ruoting Tang, Hanzhi Li, Guangliang He, Jianjin Guo, Sijuan Ding. Integrated network pharmacology, molecular docking, and experimental validation reveal synergistic inhibition of EGFR and PI3K-Akt/JAK2-STAT3 pathways by Esculin and Esculetin to exert anti-colorectal cancer effects. Toxicology and Applied Pharmacology 2026; doi: 10.1016/j.taap.2026.117981
|
| 19 |
Deerush Kannan Sakthivel, Pushan Prabhakar, Mohamed Javid Raja Iyub, Rohan Garje, Murugesan Manoharan. Comparative Analysis of Signet Ring and Non-Signet Ring Urachal Adenocarcinomas: A National Cancer Database Study. Clinical Genitourinary Cancer 2026; 24(2) doi: 10.1016/j.clgc.2025.102495
|
| 20 |
Yao Liu, Congcong Cheng, Wenling Li, Jisheng Gu, Yiheng Shi, Sujuan Fei. Machine learning-based prediction of short-term recurrence of colorectal adenomatous polyps following EMR: model development and validation study. International Journal of Medical Informatics 2026; 206 doi: 10.1016/j.ijmedinf.2025.106165
|
| 21 |
Ramakrushna Paul, Anasuya Roychowdhury. Circadian disruption in colorectal cancer: Promise of chronotherapy as precision medicine. Biochemical and Biophysical Research Communications 2026; 823 doi: 10.1016/j.bbrc.2026.153923
|
| 22 |
Lanyue Zhang, Jiangnan Zhao, Guanghui Cheng, Jiaxin Wu, Yunhao Liu, Guo Lei, Qin Wang. Inflammasomes meet organoids and artificial intelligence: unraveling the complexity of gynecological inflammation. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1753651
|
| 23 |
Younggwang Kim. A comparative genomic analysis of left- and right-sided colon cancer using real-world data from the AACR project GENIE BPC dataset. American Journal of Cancer Research 2025; 15(9) doi: 10.62347/JOGM1897
|
| 24 |
K.W. CHANG, H. TANG, L.J. FU, Q. XIA, Z.Y. PAN, J.L. TAN, V. LYSENKO, Y. GUO. Recent advances in plant stress analysis using chlorophyll a fluorescence. Photosynthetica 2025; 63(4) doi: 10.32615/ps.2025.037
|
| 25 |
Jiatian Chen, Jinting Zhao, Xiaoxiao Zhang, Huirong Zhu. Gut microbiota regulation and Traditional Chinese Medicine syndrome differentiation in right- and left-sided colon cancer heterogeneity — A review. Frontiers in Pharmacology 2026; 17 doi: 10.3389/fphar.2026.1768252
|
| 26 |
Ina Bergheim, Jean Francois Cadranel, Jianguo Chen, Wenxing Ding, Robert Eferl, Carmen Garcia-Ruiz, Hartmut Jaeschke, Firouzeh Kazerouni, Amedeo Lonardo, Derek A. Mann, Nahum Méndez-Sánchez, Camelia Mokhtari, Han Moshage, Chiara Raggi, Pavel Strnad, Oren Tirosh, Honoré Tegwende Zougmore, Jose C Fernandez-Checa. Understanding liver and digestive diseases: a paved road to improve diagnosis, management, and treatment. Exploration of Digestive Diseases 2026; 5 doi: 10.37349/edd.2026.1005110
|
| 27 |
Yifan Wei, Hua Hao. S100A8/A9 as a key player in colorectal cancer: from diagnosis to therapeutic targeting. Frontiers in Pharmacology 2026; 17 doi: 10.3389/fphar.2026.1859041
|
| 28 |
Mengqi Ding, Nan Ling, Chaojun Wei, Jiangping Liu. Commentary: Predictive value of serum miR-21 and miR-122 expression on the efficacy of capecitabine combined with transcatheter hepatic arterial embolization chemotherapy for liver metastasis after colorectal cancer surgery in patients with colorectal cancer and construction and verification of nomograms. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1668214
|
| 29 |
Yasemin Başbınar, Ömer Akgüller, Asım Leblebici, Gizem Çalıbaşı Koçal, Mehmet Ali Balcı, Zerrin Isik, Hülya Ellidokuz. DDR2-COL11A1 Transcriptional Coupling as a Candidate Therapeutic Target in Colorectal Cancer: Integrative Transcriptomic and Deep Learning Validation. International Journal of Molecular Sciences 2026; 27(5) doi: 10.3390/ijms27052509
|